Table 2.
PTCH1-GLI1 positive mesenchymal tumors: clinicopathologic and immunophenotypic characteristics
| Case # | Age/Sex | Site | IHC | Follow-up | References |
|---|---|---|---|---|---|
| 1 | 32/F | Submandibular ST/neck | S100 (+) | LR, mets to LN and lung, AWD 123 mo | [2, 11] |
| 2 | 38/M | Tongue |
S100 (+) CD56 (+) |
NED 2 mo | [11] |
| 3 | 13/M | Thorax |
S100 (+) CD56 (+) |
NED 84 mo | [12] |
| 4 | 34/F | Soft palate |
S100 (F+) CD56 (F+) D2-40 (+) |
NED 4 mo | Recent case |
AWD alive with disease; NED alive with no evidence of disease; F female; F + focally positive; LN lymph nodes; LR local recurrence; M male; met metastasis; mo months; + positive; ST soft tissue